Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

The Contribution of QF-PCR and pathology studies in the diagnosis of diandric triploidy/partial mole

dc.contributor.authorBenitez, Leticia
dc.contributor.authorPauta, Montse
dc.contributor.authorBadenas Orquin, Celia
dc.contributor.authorMadrigal Bajo, Irene
dc.contributor.authorNadal Serra, Alfons
dc.contributor.authorMarimon, Edda
dc.contributor.authorBorrell, Antoni
dc.date.accessioned2021-11-11T12:56:08Z
dc.date.available2021-11-11T12:56:08Z
dc.date.issued2021-09-30
dc.date.updated2021-11-11T12:56:08Z
dc.description.abstractObjective: the aim of our study was to assess the contribution of quantitative fluorescent polymerase chain reaction (QF-PCR) and pathology studies in the diagnosis of diandric triploidies/partial hydatidiform moles. Methods: this study included all fet al triploidies diagnosed by QF-PCR in chorionic villi or amniotic fluid in the 2 centers of BCNatal in which a maternal saliva sample was used to establish its parental origin. Pathology studies were performed in products of conception and concordance between a partial hydatidiform mole diagnosis and the finding of a diandric triploidy was assessed. Results: among 46 fetal triploidies, found in 13 ongoing pregnancies and in 33 miscarriages, there were 26 (56%) diandric triploidies. Concordant molecular (diandric triploidy) and pathology results (partial mole) were achieved in 14 cases (54%), while in 6 cases (23%) pathology studies were normal, and in the remaining 6 cases (23%) pathology studies could not be performed because miscarriage was managed medically. Conclusions: diandric triploidy is associated with partial hydatidiform mole and its diagnosis is crucial to prevent the development of persistent trophoblastic disease. QF-PCR analysis in chorionic villi or amniotic fluid provides a more accurate diagnosis of the parental origin of triploidy than the classical pathology studies
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec714479
dc.identifier.issn2075-4418
dc.identifier.pmid34679509
dc.identifier.urihttps://hdl.handle.net/2445/181200
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/diagnostics11101811
dc.relation.ispartofDiagnostics, 2021, vol. 11, num. 10, p. 1811
dc.relation.urihttps://doi.org/10.3390/diagnostics11101811
dc.rightscc-by (c) Benítez, Leticia et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Fonaments Clínics)
dc.subject.classificationReacció en cadena de la polimerasa
dc.subject.otherPolymerase chain reaction
dc.titleThe Contribution of QF-PCR and pathology studies in the diagnosis of diandric triploidy/partial mole
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
714479.pdf
Mida:
551.19 KB
Format:
Adobe Portable Document Format